Patient Follow Services
-
Manufactured by ImCare Biotech, LLCbased in USA
Overexpression of a novel apoptosis inhibitor, serine protease inhibitor Kazal (SPIK), has been demonstrated in HCC and other cancer patients. In addition, high levels of SPIK are closely associated with early recurrence in cancer patients following surgical resection. Because recurrence of cancer often implies the immune system’s ...
-
Manufactured by Firalis Groupbased in FRANCE
Firalis has extensive experience in data analysis and utilizes innovative techniques to identify novel biomarker candidates for diagnostics, patient stratification and follow-up or treatment response. Our statistical department can support your projects with the analysis and integration of multidimensional data through the lifecycle of ...
-
based in USA
Deliver effective treatments to your patients. Our clinically validated software programs are designed to deliver effective treatments to your patients while offering the favorable safety profile inherent to a digital ...
-
based in USA
Drawing upon our deep consumer expertise and proven virtual care experience, Teladoc Health delivers a Primary Care service that people love and use. From the annual exam and everyday health needs to managing chronic conditions and more complex challenges, members build an ongoing virtual care relationship with their primary care ...
-
Manufactured by ApiFix Ltd.based in ISRAEL
The first ApiFix procedure was performed in April 2012. Since then, more than 500 AIS patients have been treated with the ApiFix procedure. During this time, the implant system, surgical technique, and patient indications have evolved, resulting in steadily improved ...
-
Manufactured by Foundation Medicine, Inc.based in USA
Simplified test results provide information about genomic findings and biomarkers and their associated targeted therapies when available. We also provide information on clinically relevant alterations and available clinical trial options specific to each patient’s ...
-
based in INDIA
The liver specialist usually suggests this evaluation once he has diagnosed end-stage liver disease. Recipient evaluation is done in three phases and normally takes 5-7 days in ...
-
by Enhatch Inc.based in USA
Defining a successful surgery happens outside the operating room. Technology has advanced so that patient movements can be tracked and data can be sent directly to the surgeon to monitor recovery. Wearables can help identify or even prevent post-surgical complications as well as allow physical therapy to be completed remotely. ...
-
Manufactured by MorphoSys AGbased in GERMANY
Expanded Access to our Investigational Medicinal Products Policy. At MorphoSys, our mission is to make innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Before these and all other investigational medicinal products can be made broadly available, the U.S. Food and Drug Administration (FDA) and ...
-
Manufactured by Colibri Heart Valve LLCbased in USA
-generation TAVI system includes enhancements to address a wider range of patient candidates including those with bicuspid aortic valves and younger patients that need a more durable valve. ...
-
based in INDIA
According to international guidelines, any patient suffering from liver cirrhosis who is assessed to have a life expectancy of less than a year should be considered for a transplant. Severity of liver disease is graded from A to C. Usually all Grade C and most grade B patients are candidates for transplant. ...
-
based in GERMANY
Before sending samples to the laboratory it is helpful to contact our Service Manager so that your laboratory´s details can be set in the system. This will ensure that results are sent to the correct site in the format you require. Most aspects of our service can be personalised to meet your requirements and by contacting us before sending samples, special arrangements can be made to ensure ...
-
by ICON plcbased in IRELAND
ICON's cardiovascular trial experience, supported by a global team of experts. ICON has extensive experience in cardiovascular clinical research trials across the entire drug development spectrum. There is still significant unmet need within select cardiovascular/metabolic (CVM) disorders. Unfortunately, the cost of developing drugs and devices in this area has been rising steadily. ICON, a full ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you